Cost analysis of patients undergoing allogeneic stem cell transplantation or chimeric antigen receptor T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma from a German healthcare payer perspective

P. Ahmadi, S. Ghandili, F. Jakobs, C. Konnopka, A. Morgner-Miehlke, N. Kröger,F. Ayuk

Bone Marrow Transplantation(2024)

Cited 0|Views2
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined